Michael Taylor
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Mr. Michael Taylor is an Independent Director at NRX Pharmaceuticals, Inc. He is on the Board of Directors at NRX Pharmaceuticals, Inc. Mr. Taylor was previously employed as a Partner by Adi Dassler International Family Office LLC, a Managing Director by Oppenheimer & Co., Inc., and a MD-Institutional Fixed Income Trading by Stone & Youngberg LLC.
He received his undergraduate degree from London School of Economics & Political Science.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/02/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NRX PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 15/01/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
Adi Dassler International Family Office LLC | Corporate Officer/Principal | 14/02/2023 |
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Corporate Officer/Principal | 01/08/2016 |
Stone & Youngberg LLC
Stone & Youngberg LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/06/2011 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Provides wealth and asset management, brokerage & investment banking services | Finance |
Stone & Youngberg LLC
Stone & Youngberg LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
London School of Economics & Political Science
London School of Economics & Political Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adi Dassler International Family Office LLC | |
NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a molecule pharmaceutical company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national